Showing results (351-360 of 1,188) with videos related to

Sort By:
Pageof 119
Cancer Genetics|May 3, 2016
Whole-arm translocation of der(5;17)(p10;q10) with concurrent TP53 mutations in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): A unique molecular-cytogenetic subgroupMing Hong, Suyang Hao, Keyur P Patel, et al.
Leukemia & Lymphoma|August 15, 2014
Incidence of secondary neoplasms in patients with acute promyelocytic leukemia treated with all-trans retinoic acid plus chemotherapy or with all-trans retinoic acid plus arsenic trioxideAlireza Eghtedar, Ildefonso Rodriguez, Hagop Kantarjian, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2011
Echinocandin susceptibility testing of Candida spp. Using EUCAST EDef 7.1 and CLSI M27-A3 standard procedures: analysis of the influence of bovine serum albumin supplementation, storage time, and drug lotsMaiken Cavling Arendrup, Juan-Luis Rodriguez-Tudela, Steven Park, et al.
British Journal of Haematology|June 18, 2010
Clinical impact of dose reductions and interruptions of second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemiaFabio P S Santos, Hagop Kantarjian, Carmen Fava, et al.
Cancer|September 19, 2008
Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 yearsHagop Kantarjian, Susan O'Brien, Jorge Cortes, et al.
Surgical Neurology International|April 21, 2021
Invisible compression, anterior fossa tumor causing trigeminal neuralgiaJesus Manuel Esteban Garcia, David Mato Mañas, Enrique Marco De Lucas, et al.
Blood|August 2, 2011
The achievement of an early complete cytogenetic response is a major determinant for outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitorsElias Jabbour, Hagop Kantarjian, Susan O'Brien, et al.
Leukemia Research|November 3, 2009
Outcome of patients with FLT3-mutated acute myeloid leukemia in first relapseFarhad Ravandi, Hagop Kantarjian, Stefan Faderl, et al.
Cellular and Molecular Bioengineering|June 28, 2013
Heparan Sulfate Regrowth Profiles Under Laminar Shear Flow Following Enzymatic DegradationKristina M Giantsos-Adams, Andrew Jia-An Koo, Sukhyun Song, et al.
Cancer|March 1, 2014
Disparity in perceptions of disease characteristics, treatment effectiveness, and factors influencing treatment adherence between physicians and patients with myelodysplastic syndromesDavid P Steensma, Rami S Komrokji, Richard M Stone, et al.
Pageof 119